CYCC
Cyclacel Pharmaceuticals Inc
NASDAQ: CYCC · HEALTHCARE · BIOTECHNOLOGY
$6.37
+0.00% today
Updated 2026-04-29
Market cap
$14.25M
P/E ratio
0.00
P/S ratio
1,425.11x
EPS (TTM)
$7,123.50
Dividend yield
—
52W range
$3 – $98
Volume
—
Cyclacel Pharmaceuticals Inc (CYCC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.51M | $-20.17M | $-23.14M | $-29.91M | $-15.19M | $-16.04M | $-13.98M | $-12.04M | $-18.20M | $-18.70M | $-14.46M | $-10.08M | $-7.48M | $-6.70M | $-9.45M | $-7.93M | $-18.54M | $-20.83M | $-16.11M | $-7.99M |
| Capital expenditures | $900000.00 | $667000.00 | $1.77M | $366000.00 | $15000.00 | $8000.00 | $6000.00 | $12000.00 | $208000.00 | $309000.00 | $34000.00 | $3000.00 | $13000.00 | $39000.00 | $10000.00 | $96000.00 | $27000.00 | $7000.00 | $6000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.20M | — | — | $1.70M | $810000.00 | $1.75M | $882000.00 | $380000.00 | $357000.00 | $1.22M | $745000.00 | $782000.00 | $266000.00 | $331000.00 | $466000.00 | $430000.00 | $1.16M | $1.51M | $1.47M | $592000.00 |
| Free cash flow | $-22.41M | $-20.84M | $-24.91M | $-30.27M | $-15.21M | $-16.05M | $-13.98M | $-12.05M | $-18.41M | $-19.01M | $-14.49M | $-10.08M | $-7.49M | $-6.74M | $-9.46M | $-8.03M | $-18.57M | $-20.83M | $-16.12M | $-7.99M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $1.22M | $921000.00 | $1.22M | $1.23M | — | — | $364000.00 | $0.00 | $305000.00 | $200000.00 | $201000.00 | $200000.00 | $201000.00 | $201000.00 | $201000.00 | $201000.00 | $201000.00 | $201000.00 | $201000.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | $14.73M | — | $-3.75M | $-3.92M | $7.39M | $-6.41M | $-5.57M | $21.47M | — | — | — | — |